‘Their Rubber Stamp Is Reckless’: After AAP Endorses Weight-Loss Drugs for Kids, Prescriptions Soar

‘Their Rubber Stamp Is Reckless’: After AAP Endorses Weight-Loss Drugs for Kids, Prescriptions Soar

Researchers who analyzed more than 310,000 health records found that prescriptions for GLP-1 drugs for…

Children's Health Defense

by Brenda Baletti, Ph.D.

Prescriptions for GLP-1 weight-loss drugs for kids and teens grew substantially after the American Academy of Pediatrics (AAP) in 2023 recommended them for childhood obesity, according to a new study published in the AAP’s flagship journal Pediatrics.

GLP-1 drugs, typically used to treat obesity or diabetes, include the blockbuster drugs Ozempic, Wegovy, Mounjaro and Saxenda. Of those, only Wegovy and Saxenda are approved for children. However, several lesser-known GLP-1 drugs can be prescribed off-label for children.

Researchers with the health data and analytics company Truveta analyzed more than 310,000 health records. They found that prescriptions for GLP-1 drugs for children and teens ages 8-17 increased 65% immediately following AAP’s recommendation and another 5% per month after that, Axios reported…

READ FULL ARTICLE HERE… (childrenshealthdefense.org)

Home | Caravan to Midnight (zutalk.com)

We Need Your Help To Keep Caravan To Midnight Going,

Please Consider Donating To Help Keep Independent Media Independent